Literature DB >> 3968122

Optimizing tourniquet application and release times in extremity surgery. A biochemical and ultrastructural study.

A A Sapega, R B Heppenstall, B Chance, Y S Park, D Sokolow.   

Abstract

Despite numerous studies investigating the pathophysiology of tourniquet ischemia, definitive data at the cellular level have been lacking and no consensus regarding safe tourniquet-application times in extremity surgery has emerged. In light of the particular vulnerability of skeletal muscle to ischemic injury, we determined the degree of muscular metabolic derangement and cell damage produced by seven different protocols of tourniquet application and release, each providing three hours of total tourniquet time. We performed thirty-six experiments on canine hind limbs, comparing the following time-patterns of tourniquet application: I--three sequential one-hour periods, II--two sequential one and one-half-hour periods, III--two hours followed by one hour, and IV--a single continuous three-hour application. Five and fifteen-minute reperfusion intervals between ischemic periods were compared for the first three time-patterns, creating a total of seven different tourniquet protocols. Muscular metabolic derangement and cell injury were evaluated by monitoring changes in the cellular bioenergetic state (high-energy phosphate profile), cell pH, post-ischemic leakage of creatine phosphokinase, and ultrastructural cell degeneration. At the intracellular level, the metabolic recovery of muscle during reperfusion was much faster than previous studies focusing on extracellular parameters have indicated. In all instances complete intracellular bioenergetic recovery occurred within five minutes after tourniquet release. The use of one or more five-minute reperfusion intervals significantly reduced the degree of ischemic cell injury, as indicated by a decrease in creatine phosphokinase leakage and myofibrillar destruction. No additional benefit was derived by extending the reperfusion periods to fifteen minutes. The longest period of continuous ischemia in each tourniquet-application protocol bore the closest relationship with the amount of cell damage produced. Within the spectrum of observed pathological changes, time-patterns I and II produced comparatively little muscle damage.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3968122

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  25 in total

1.  Tourniquet use in upper limb surgery.

Authors:  Emeka Oragui; Antony Parsons; Thomas White; Umile Giuseppe Longo; Wasim Sardar Khan
Journal:  Hand (N Y)       Date:  2010-12-08

2.  Voluntary running protects against neuromuscular dysfunction following hindlimb ischemia-reperfusion in mice.

Authors:  Rebecca J Wilson; Joshua C Drake; Di Cui; Matthew L Ritger; Yuntian Guan; Jarrod A Call; Mei Zhang; Lucia M Leitner; Axel Gödecke; Zhen Yan
Journal:  J Appl Physiol (1985)       Date:  2018-11-15

Review 3.  Ischemia/Reperfusion.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Compr Physiol       Date:  2016-12-06       Impact factor: 9.090

4.  Rhabdomyolysis from tourniquet trauma in a patient with hypothyroidism.

Authors:  P L Vold; P J Weiss
Journal:  West J Med       Date:  1995-03

5.  Tourniquet and adrenaline use in hypospadias surgery: a survey on the current practice in Turkey.

Authors:  Ufuk Ateş; Günay Ekberli; Nil Yaşam Taştekin; Gülnür Göllü; Murat Çakmak
Journal:  Turk J Urol       Date:  2018-11-21

Review 6.  Cell biology of ischemia/reperfusion injury.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

7.  Benefits of Limited Use of a Tourniquet Combined With Intravenous Tranexamic Acid During Total Knee Arthroplasty.

Authors:  Alexander D Rosenstein; Yehuda A Michelov; Stephanie Thompson; Alan D Kaye
Journal:  Ochsner J       Date:  2016

8.  A case of rhabdomyolysis associated with use of a pneumatic tourniquet during arthroscopic knee surgery.

Authors:  Yong Gu Lee; Woong Park; Sang Hoon Kim; Sang Pil Yun; Hun Jeong; Hyung Jong Kim; Dong Ho Yang
Journal:  Korean J Intern Med       Date:  2010-02-26       Impact factor: 2.884

9.  Clinical outcomes of two minimally invasive transforaminal lumbar interbody fusion (TLIF) for lumbar degenerative diseases.

Authors:  Yonghao Tian; Xinyu Liu
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-03-04

10.  Effect of limited ischemia time on the amount and function of mitochondria within human skeletal muscle cells.

Authors:  A Jawhar; N Ponelies; L Schild
Journal:  Eur J Trauma Emerg Surg       Date:  2015-11-25       Impact factor: 3.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.